Clinical trials
Phase 3 COVID-19 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 10 |
| 2021 | 6 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 4 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cadila Pharnmaceuticals | 2 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
| Apogenix GmbH | 1 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Bharat Biotech International Limited | 1 |
| Eli Lilly and Company | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| NICHD Global Network for Women's and Children's Health | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 22 |
| Coronavirus Infections | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Community-Acquired Pneumonia | 2 |
| Influenza, Human | 2 |
| Lung Diseases | 2 |
| Pneumonia | 2 |
| Respiratory Tract Infections | 2 |
| Cardiovascular Diseases | 1 |
| Hypoxia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.